Serratia marcescens bacteremia. Clinical observations and studies of precipitin reactions.
D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000494:pharmacology / Q000627:therapeutic use; D000667:Ampicillin / Q000494:pharmacology; D000906:Antibodies / Q000032:analysis*; D001437:Bacteriuria / Q000382:microbiology; D002512:Cephalothin / Q000494:pharmacology / Q000627:therapeutic use; D002701:Chloramphenicol / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D005779:Immunodiffusion; D007612:Kanamycin / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009268:Nalidixic Acid / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology / Q000627:therapeutic use; D011233:Precipitin Tests; D018805:Sepsis / Q000150:complications / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000382:microbiology; D012706:Serratia marcescens / Q000187:drug effects / Q000276:immunology / Q000302:isolation & purification; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin / Q000494:pharmacology / Q000627:therapeutic use; D013752:Tetracycline / Q000494:pharmacology
D000906:Antibodies; D005839:Gentamicins; D010406:Penicillins; D009268:Nalidixic Acid; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D000666:Amphotericin B; D013752:Tetracycline; D002512:Cephalothin; D013307:Streptomycin